
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/">
  <dc:language>eng</dc:language>
  <dc:format>application/pdf</dc:format>
  <dc:format>9167561 bytes</dc:format>
  <dc:date>2021</dc:date>
  <dc:subject xml:lang="eng">Key words: atrial fibrillation, left atrial diameter, left ventricular ejection fraction, CHA2DS2 -VASc score, pulmonary vein isolation</dc:subject>
  <dc:identifier>https://unilib.phaidrabg.rs/o:2868</dc:identifier>
  <dc:identifier>doi:10.3390/jcm10245827</dc:identifier>
  <dc:identifier>cobiss:125450249</dc:identifier>
  <dc:identifier>ISSN: 2077-0383</dc:identifier>
  <dc:type>info:eu-repo/semantics/article</dc:type>
  <dc:description xml:lang="eng">ABSTRACT: This study introduces the pulmonary vein isolation outcome degree (PVIOD) as a new
semiquantitative measure for the efficacy of atrial fibrillation (AF) catheter ablation and reports the
determination of predictors associated with PVIOD. The median follow-up periods of 117 patients
after the first and last ablation were, respectively, 82 (IQR 15) and 72 (IQR 30) months. PVIOD 1
included 32.5% of patients, those with successful single pulmonary vein isolation (PVI); PVIOD
2 included 29.1% of subjects, those with success after multiple procedures; PVIOD 3 comprised
14.5% of patients, those with clinical success; and PVIOD 4 included 23.9% of cases, those with
procedural and clinical failure. In the multivariate ordinal logistic regression analysis, PVIOD 1–4
were independently associated with longstanding persistent AF with paroxysmal AF as the referent
category (odds ratio (OR), 3.5; 95% confidence interval (95% CI), 1.1–10.7 (p = 0.031)), left atrial (LA)
diameter (OR, 1.2; 95% CI, 1.1–1.3 (p = 0.001)) and left ventricular ejection fraction (LVEF) (OR, 0.9;
95% CI, 0.86–1.0 (p = 0.038)). LA size &gt; 41 mm, LVEF ≤ 50% and longstanding persistent AF are
strong predictors of AF recurrence. PVIOD 1–4 offer the most exact long-term prognosis of PVI. The
purpose of the present article is to expand the quantitative measure of procedural success in the
medical and biological fields.
</dc:description>
  <dc:rights>http://creativecommons.org/licenses/by/4.0/legalcode</dc:rights>
  <dc:creator id="https://orcid.org/0000-0002-6433-6860 https://plus.cobiss.net/cobiss/sr/sr/conor/4163943">Jurčević, Ružica</dc:creator>
  <dc:creator id="https://orcid.org/0000-0002-9136-4971 https://plus.cobiss.net/cobiss/sr/sr/conor/619111">Angelkov, Lazar</dc:creator>
  <dc:creator id="https://orcid.org/0000-0003-2465-1708 https://plus.cobiss.net/cobiss/sr/sr/conor/12750439">Tasić, Nebojša</dc:creator>
  <dc:creator id="https://orcid.org/0000-0002-2190-5701 https://plus.cobiss.net/cobiss/sr/sr/conor/10184551">Tomović, Milosav</dc:creator>
  <dc:creator id="https://orcid.org/0000-0001-9107-4520 https://plus.cobiss.net/cobiss/sr/sr/conor/54503433">Kojić, Dejan</dc:creator>
  <dc:creator id="https://orcid.org/0000-0002-0362-5765 https://plus.cobiss.net/cobiss/sr/sr/conor/12787303">Otašević, Petar</dc:creator>
  <dc:creator id="https://orcid.org/0000-0002-0051-041X https://plus.cobiss.net/cobiss/sr/sr/conor/1394535">Bojić, Milovan</dc:creator>
  <dc:source>Journal of clinical medicine 10(24)</dc:source>
  <dc:title xml:lang="eng">Pulmonary vein isolation outcome degree is a new score for efficacy of atrial fibrillation catheter ablation</dc:title>
</oai_dc:dc>
